Fujifilm has announced significant price hikes across its camera and instant-print ranges in Japan, citing increased material, manufacturing, and logistics costs, with a broader industry trend pushing prices higher globally.
Fujifilm has increased prices in Japan across parts of its camera and instant-print range, with the company citing higher material, manufacturing and logistics costs. According to Fujifilm Imaging Systems, the changes took effect on 1 October and cover selected digital cameras, interchangeable lenses and instax products. The revision follows a short notice period, with the company issuing its announcement only a day before the new pricing began.
The steepest increases appear to be in instax products, where some models are reported to have risen by as much as 23%, while digital cameras are said to be up by between 6% and 15%. The affected lineup includes the GFX100 II, GFX100S II, GFX100RF, X-T50, X-E5 and X100VI, alongside related kit bundles. Fujifilm also named the XF500mmF5.6 R LM OIS WR lens among the products subject to a higher price.
The move matters beyond Japan because Fujifilm has already lifted prices in Europe over the summer. Reports cited increases of roughly 6% to 11%, with the GFX100 II now around €500 more expensive than it was in July and the X100VI rising from €1,799 at launch to €1,999. Availability remains tight, and some retailers are still showing long lead times for the popular compact camera.
The wider industry backdrop suggests Fujifilm is not alone. According to reporting from several specialist outlets, Canon, GoPro, Leica, Nikon and Sony have all warned that memory-related costs could force further price rises, with supply constraints in memory chips and volatility in silver prices adding pressure across different product categories. In the US, where Fujifilm prices were already raised during the 2025 tariff dispute, another increase remains possible if component costs continue to climb.
Disclaimer: This content is intended for informational purposes only. Readers are advised to exercise their own judgement, conduct due diligence, or consult a qualified expert before acting on any information provided.
